Editing Baker Pharmaceuticals
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision
Your text
Line 1:
Line 1: − {{InfoBoxCorporation+ ''(References to [[Special:Whatlinkshere/Baker Pharmaceuticals | Baker Pharmaceuticals]])'' − | image = + − | Founded = + '''Baker Pharmaceuticals''' is a pharmaceutical company in the [[Lyran Commonwealth]].<ref>''House Steiner (The Lyran Commonwealth)'', p. 142, "Other Major Commonwealth Industries"</ref> − | Dissolved = − | Previous Names = − | headquarters = New Benner<br/>([[Baker 3]])<ref name=HSTLC-142/> − | leadership = [[CEO of Baker Pharmaceuticals|CEO]] − | products = − | Parent Corporation = − | Division = − }} − '''Baker Pharmaceuticals''' was a pharmaceutical company in the [[Lyran Commonwealth]], with its assets eventually acquired by the mammoth [[Nashan Diversified]]. <ref name=HSTLC-142>''House Steiner (The Lyran Commonwealth)'', p. 142 "Socioeconomics - Other Major Commonwealth Industries - Baker Pharmaceuticals"</ref> <ref name=HHS-134>''Handbook: House Steiner'', p. 134 - "Economics - Major Industries- Nashan Diversified".</ref> ==Company Profile== ==Company Profile== − '''Commonwealth Stock Exchange Symbol:''' BakPhar. <ref name=HSTLC-142/> + '''Commonwealth Stock Exchange Symbol:''' BakPhar − '''President/CEO:''' [[John Sleeth]] (circa 3024).<ref name=HSTLC-142/> + '''Home Office:''' New Benner, [[Baker 3]] − ==Overview==+ '''President/CEO:''' John Sleeth − Baker Pharmaceuticals had been in business with the Lyran Commonwealth for many years but encountered serious financial and personnel problems after losing a 300-million-[[Kroner|S-Bill]] lawsuit in [[3023]] when a batch of their synthetic molecular antibodies went toxic, killing over 100 [[Lyran Commonwealth Armed Forces]] soldiers. Like a shark smelling blood in the water, Nashan Diversified launched a takeover attempt in [[3024]], which Baker CEO John Sleeth attempted to resist by ordering his brokers to buy back all public Baker stocks at a substantially higher price than Nashan's offer.<ref name=HSTLC-142/> − While saving the company in the short-term, the heavy financial burden of the buy-back forced BP to cut costs and let go staff, leaving it in dire straits with many observers questioning if the company would survive beyond [[3025]].<ref name=HSTLC-142/> Nashan would ultimately succeed in acquiring Baker Pharmaceuticals, but rather than reorganize and integrate the company's Baker 3 headquarters into the Nashan family, Nashan chose to virtually liquidate BP and transfer its remaining assets to Nashan's newer [[Donegal]] offices to serve as its '''Nashan Pharmaceuticals''' division.<ref name=HHS-134/>+ Baker Pharmaceuticals has been in business with the Lyran Commonwealth for many years. In [[3023]], the company paid a 300 million credit lawsuit when a batch of their synthetic antibodies went toxic and killed over 100 soldiers of the [[LCAF]]. To prevent a takeover of the company by [[Nashan Diversified]], the company president, John Sleeth, authorized the buy back of all public owned stock at a higher price than Nashan was offering. This has led the company to cut costs, staff and operations. As of [[3025]], the company has been faced with many problems and many wonder if it will survive the year. ==References== ==References== Line 27:
Line 17: ==Bibliography== ==Bibliography== − *''[[Handbook: House Steiner]]'' *''[[House Steiner (The Lyran Commonwealth)]]'' *''[[House Steiner (The Lyran Commonwealth)]]'' − [[Category:Lyran Commonwealth Corporations]] + [[Category:Companies]]
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
| Latest revision | Your text | ||
| Line 1: | Line 1: | ||
| − | + | ''(References to [[Special:Whatlinkshere/Baker Pharmaceuticals | Baker Pharmaceuticals]])'' | |
| − | + | ||
| − | + | '''Baker Pharmaceuticals''' is a pharmaceutical company in the [[Lyran Commonwealth]].<ref>''House Steiner (The Lyran Commonwealth)'', p. 142, "Other Major Commonwealth Industries"</ref> | |
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | '''Baker Pharmaceuticals''' | ||
==Company Profile== | ==Company Profile== | ||
| − | '''Commonwealth Stock Exchange Symbol:''' BakPhar | + | '''Commonwealth Stock Exchange Symbol:''' BakPhar |
| − | ''' | + | '''Home Office:''' New Benner, [[Baker 3]] |
| − | + | '''President/CEO:''' John Sleeth | |
| − | |||
| − | + | Baker Pharmaceuticals has been in business with the Lyran Commonwealth for many years. In [[3023]], the company paid a 300 million credit lawsuit when a batch of their synthetic antibodies went toxic and killed over 100 soldiers of the [[LCAF]]. To prevent a takeover of the company by [[Nashan Diversified]], the company president, John Sleeth, authorized the buy back of all public owned stock at a higher price than Nashan was offering. This has led the company to cut costs, staff and operations. As of [[3025]], the company has been faced with many problems and many wonder if it will survive the year. | |
==References== | ==References== | ||
| Line 27: | Line 17: | ||
==Bibliography== | ==Bibliography== | ||
| − | |||
*''[[House Steiner (The Lyran Commonwealth)]]'' | *''[[House Steiner (The Lyran Commonwealth)]]'' | ||
| − | [[Category: | + | [[Category:Companies]] |